Medical Xpress news

Medical Xpress / Gut bacteria molecule boosts lung cancer treatment response

UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer immunotherapy treatment in mice and can now be made into a drug for testing ...

Jan 14, 2026 in Oncology & Cancer
Medical Xpress / HIF1 protein identified as key trigger in common tendon diseases

Complaints such as pain in the Achilles tendon, tennis elbow, swimmer's shoulder and jumper's knee are familiar to many young sportspeople, as well as to older individuals. These conditions are all caused by overloading of ...

Medical Xpress / How a unique class of neurons may set the table for brain development

The way the brain develops can shape us throughout our lives, so neuroscientists are intensely curious about how it happens. A new study by researchers in The Picower Institute for Learning and Memory at MIT that focused ...

Jan 14, 2026 in Neuroscience
Medical Xpress / Age-specific treatments for the same infection may be critical as antibiotic resistance crisis intensifies

Dealing with an infection isn't as straightforward as simply killing the pathogen. The body also needs to carefully steer and monitor its immune response to prevent collateral damage. This regulation, called disease tolerance, ...

Medical Xpress / Faking a ketogenic diet may still get results—in fruit flies

Mimicking a ketogenic diet lengthens lifespan but reduces fertility in fruit flies, researchers at the University of Connecticut and Mount Holyoke College report in Developmental Biology. The study hints that there could ...

Jan 14, 2026 in Medical research
Medical Xpress / Study suggests bamboo has 'superfood' potential

The world's first academic review into bamboo consumption has identified a surprising range of health benefits, including helping control blood sugar, fighting inflammation, improving gut health and acting as an antioxidant.

Jan 14, 2026 in Medical research
Medical Xpress / Researchers revive an abandoned depression drug target using structurally novel NK1 receptor inhibitors

For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major depressive disorder. Early studies suggested promise, but enthusiasm faded after clinical trials of drugs ...

Jan 14, 2026 in Medications
Medical Xpress / New model fails to explain near-death experiences, scientists say

An ambitious effort to create a neurophysiological paradigm to explain near-death experiences has failed to capture many fascinating and often perplexing aspects of people's brushes with death, top University of Virginia ...

Jan 14, 2026 in Psychology & Psychiatry
Medical Xpress / Prenatal and early-life pollution exposures may influence childhood blood pressure patterns, study finds

A child's blood pressure may be influenced by exposure to air pollution before and shortly after birth, according to a study from the Environmental influences on Child Health Outcomes (ECHO) Program. The study focused on ...

Jan 14, 2026 in Cardiology
Medical Xpress / Researchers uncover hundreds of emojis in patient records

Analysis of 218.1 million notes from 1.6 million patients' electronic health records revealed growing use of emojis.

Jan 14, 2026 in Health informatics
Medical Xpress / Discrimination damages the body—and makes victims age faster

Has being discriminated against as an LGBTQ+ person been so bad, the stress so heavy, that the victim can literally feel it in their bones? Well, it turns out that's exactly what happens: discrimination damages the body and ...

Jan 14, 2026 in Psychology & Psychiatry
Medical Xpress / CBD treatment reverses key effects of fetal alcohol spectrum disorder in mouse model

Cannabidiol (CBD) could become a therapeutic tool to address some of the most frequent and disabling consequences of fetal alcohol spectrum disorder (FASD), a condition caused by alcohol exposure during pregnancy. This is ...

Jan 14, 2026 in Addiction